Business Context and Reporting Period
This Form 8-K Current Report from Lifemd, Inc. (LFMD) covers the Annual Meeting of Stockholders held on June 16, 2023. The filing details the submission of matters to a vote of security holders and the resulting outcomes.
Key Financial Metrics
This filing does not contain financial performance data. There are no reported figures for revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes and Voting Results
The filing reports the approval of two proposals by the Company's stockholders:
- Proposal 1 (Election of Directors): Nine directors were elected to serve until the next annual meeting. All nominees received a majority of votes cast.
- Proposal 2 (Ratification of Auditors): Stockholders ratified the selection of Marcum LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2023.
Voting Summary:
- Quorum: A majority in interest of all stock issued, outstanding, and entitled to vote was present.
- Director Votes: Votes ranged from approximately 11.2 million to 13.0 million "For" per director, with "Votes Withheld" ranging from approximately 861,000 to 2.6 million. Broker non-votes were consistent at 7,226,789 for all director nominees.
- Auditor Votes: 20,184,888 votes "For," 329,773 "Against," and 607,897 "Abstained."
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, risks, contingencies, or unusual items. The document is strictly limited to reporting the results of the stockholder vote.
Investor Verification Checklist
- Verify the composition of the newly elected Board of Directors.
- Confirm the engagement of Marcum LLP as the independent auditor for the 2023 fiscal year.
- Review the proxy statement for detailed biographies of the elected directors and the rationale for the auditor selection.
- Note that this filing contains no financial data; refer to the most recent 10-K or 10-Q for financial metrics.